- Home
- PCRX vs IMOS Comparison
PCRX vs IMOS Comparison
Compare PCRX & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- IMOS
- Stock Information
- Founded
- PCRX 2006
- IMOS 1997
- Country
- PCRX United States
- IMOS Taiwan
- Employees
- PCRX N/A
- IMOS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- PCRX Health Care
- IMOS Technology
- Exchange
- PCRX Nasdaq
- IMOS Nasdaq
- Market Cap
- PCRX 604.7M
- IMOS 679.2M
- IPO Year
- PCRX 2011
- IMOS N/A
- Fundamental
- Price
- PCRX $22.84
- IMOS $18.72
- Analyst Decision
- PCRX Buy
- IMOS
- Analyst Count
- PCRX 10
- IMOS 0
- Target Price
- PCRX $27.60
- IMOS N/A
- AVG Volume (30 Days)
- PCRX 787.3K
- IMOS 24.0K
- Earning Date
- PCRX 02-27-2025
- IMOS 02-20-2025
- Dividend Yield
- PCRX N/A
- IMOS 5.80%
- EPS Growth
- PCRX N/A
- IMOS 7.03
- EPS
- PCRX N/A
- IMOS 0.07
- Revenue
- PCRX $694,957,000.00
- IMOS $724,842,895.00
- Revenue This Year
- PCRX $4.83
- IMOS $11.63
- Revenue Next Year
- PCRX $2.16
- IMOS $6.29
- P/E Ratio
- PCRX N/A
- IMOS $12.86
- Revenue Growth
- PCRX 4.40
- IMOS 13.31
- 52 Week Low
- PCRX $11.16
- IMOS $17.70
- 52 Week High
- PCRX $34.01
- IMOS $32.19
- Technical
- Relative Strength Index (RSI)
- PCRX 72.97
- IMOS 48.42
- Support Level
- PCRX $18.18
- IMOS $17.70
- Resistance Level
- PCRX $22.36
- IMOS $18.60
- Average True Range (ATR)
- PCRX 1.17
- IMOS 0.38
- MACD
- PCRX 0.33
- IMOS 0.04
- Stochastic Oscillator
- PCRX 99.15
- IMOS 58.29
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.